TY - JOUR T1 - Registering our interest JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 18 LP - 18 DO - 10.1136/dtb.2020.000001 VL - 58 IS - 2 AU - David Phizackerley Y1 - 2020/02/01 UR - http://dtb.bmj.com/content/58/2/18.abstract N2 - Since 1962, DTB has been an independent voice publishing impartial articles on medicines and therapeutics to help clinicians and patients make informed and unbiased choices. In line with our publisher’s principles, we strive to be transparent about any interests that our readers might want to know about and ensure that all those involved with DTB disclose all relationships and activities that could be viewed as potential conflicts of interest and sources of bias. We recognise that the disclosure process is not perfect and too often focuses on financial matters. Nevertheless, perceptions of conflict of interest are as important as actual conflicts of interest, and we believe that it is important to allow readers to judge whether our content is independent of … ER -